Capital Analysts LLC’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.05M | Sell |
15,171
-849
| -5% | -$230K | 0.11% | 168 |
|
|
2025
Q4 | $4.02M | Sell |
16,020
-85
| -0.5% | -$22.6K | 0.11% | 156 |
|
|
2025
Q3 | $4.62M | Sell |
16,105
-505
| -3% | -$135K | 0.13% | 136 |
|
|
2025
Q2 | $4.36M | Sell |
16,610
-543
| -3% | -$132K | 0.15% | 123 |
|
|
2025
Q1 | $3.99M | Buy |
17,153
+301
| +2% | +$73K | 0.15% | 125 |
|
|
2024
Q4 | $3.87M | Sell |
16,852
-152
| -0.9% | -$34.9K | 0.16% | 114 |
|
|
2024
Q3 | $3.8M | Buy |
17,004
+108
| +0.6% | +$23.7K | 0.15% | 118 |
|
|
2024
Q2 | $3.44M | Buy |
16,896
+436
| +3% | +$88.7K | 0.15% | 116 |
|
|
2024
Q1 | $3.6M | Buy |
16,460
+48
| +0.3% | +$10.6K | 0.17% | 105 |
|
|
2023
Q4 | $3.73M | Buy |
16,412
+837
| +5% | +$176K | 0.19% | 100 |
|
|
2023
Q3 | $3.13M | Sell |
15,575
-1,923
| -11% | -$406K | 0.17% | 107 |
|
|
2023
Q2 | $3.63M | Sell |
17,498
-190
| -1% | -$36.9K | 0.2% | 98 |
|
|
2023
Q1 | $3.49M | Buy |
17,688
+415
| +2% | +$85.4K | 0.2% | 102 |
|
|
2022
Q4 | $3.49M | Buy |
17,273
+783
| +5% | +$153K | 0.21% | 95 |
|
|
2022
Q3 | $2.9M | Buy |
16,490
+568
| +4% | +$116K | 0.2% | 101 |
|
|
2022
Q2 | $3.21M | Buy |
15,922
+96
| +0.6% | +$20.5K | 0.22% | 93 |
|
|
2022
Q1 | $3.58M | Sell |
15,826
-603
| -4% | -$142K | 0.23% | 93 |
|
|
2021
Q4 | $4.43M | Sell |
16,429
-763
| -4% | -$189K | 0.27% | 77 |
|
|
2021
Q3 | $4.16M | Sell |
17,192
-466
| -3% | -$117K | 0.27% | 79 |
|
|
2021
Q2 | $4.18M | Sell |
17,658
-332
| -2% | -$75.6K | 0.28% | 77 |
|
|
2021
Q1 | $3.94M | Sell |
17,990
-639
| -3% | -$128K | 0.27% | 80 |
|
|
2020
Q4 | $3.26M | Sell |
18,629
-83
| -0.4% | -$14.3K | 0.29% | 73 |
|
|
2020
Q3 | $3.03M | Sell |
18,712
-578
| -3% | -$91.6K | 0.29% | 74 |
|
|
2020
Q2 | $2.75M | Sell |
19,290
-373
| -2% | -$51.6K | 0.29% | 80 |
|
|
2020
Q1 | $2.13M | Sell |
19,663
-368
| -2% | -$53K | 0.26% | 81 |
|
|
2019
Q4 | $2.91M | Buy |
20,031
+51
| +0.3% | +$7.36K | 0.29% | 80 |
|
|
2019
Q3 | $2.88M | Buy |
19,980
+219
| +1% | +$32K | 0.3% | 79 |
|
|
2019
Q2 | $2.94M | Sell |
19,761
-150
| -0.8% | -$20.9K | 0.32% | 76 |
|
|
2019
Q1 | $2.62M | Buy |
19,911
+626
| +3% | +$77.1K | 0.3% | 78 |
|
|
2018
Q4 | $2.09M | Sell |
19,285
-1,524
| -7% | -$204K | 0.28% | 78 |
|
|
2018
Q3 | $3.1M | Sell |
20,809
-482
| -2% | -$73.3K | 0.35% | 69 |
|
|
2018
Q2 | $3.28M | Buy |
21,291
+206
| +1% | +$31.1K | 0.39% | 63 |
|
|
2018
Q1 | $2.93M | Buy |
21,085
+313
| +2% | +$46K | 0.36% | 67 |
|
|
2017
Q4 | $2.85M | Sell |
20,772
-40
| -0.2% | -$5.29K | 0.36% | 72 |
|
|
2017
Q3 | $2.7M | Sell |
20,812
-580
| -3% | -$77.4K | 0.36% | 74 |
|
|
2017
Q2 | $2.83M | Sell |
21,392
-74
| -0.3% | -$9.06K | 0.4% | 60 |
|
|
2017
Q1 | $2.65M | Buy |
21,466
+284
| +1% | +$33.6K | 0.42% | 63 |
|
|
2016
Q4 | $2.34M | Sell |
21,182
-1,566
| -7% | -$174K | 0.41% | 72 |
|
|
2016
Q3 | $2.69M | Buy |
+22,748
| New | +$2.68M | 0.5% | 46 |
|
Other funds holding LH
VCM
VPM
Capital Analysts LLC's LH Position: Q1 2026 in Review
Capital Analysts LLC reduced its Labcorp (LH) stake by 5.3% in Q1 2026, selling an estimated $230K and leaving 15,171 shares worth $4.05M. The position accounts for 0.11% of the portfolio, ranked #168.
Capital Analysts LLC first reported a position in LH in Q3 2016 and has held it in 39 quarters since. The position peaked at $4.62M in Q3 2025. 1,032 funds tracked by Wall St. Rank hold LH as of Q1 2026.
- Capital Analysts LLC held 15,171 shares of Labcorp worth $4.05M as of Q1 2026.
- Capital Analysts LLC sold 849 Labcorp shares in Q1 2026, an estimated $230K.
- Labcorp made up 0.11% of Capital Analysts LLC's portfolio in Q1 2026, its #168 holding.
- Capital Analysts LLC first reported a position in Labcorp in Q3 2016 and has held it in 39 quarters since.
- Capital Analysts LLC's Labcorp position peaked at $4.62M in Q3 2025.
- 1,032 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.
Based on Capital Analysts LLC's 13F filing for Q1 2026, filed 14 May 2026.